Oppenheimer Reiterates Perform on Ambarella (AMBA)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq hits intraday record high on Alphabet boost, Mideast negotiation hopes
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Ambarella (AMBA) PT Lowered to $65 at Stifel
March 1, 2017 8:44 AM ESTStifel lowered its price target on Ambarella (NASDAQ: AMBA) to $65.00 (from $82.00) while maintaining a Buy rating. 4Q revenue of $87.5mn was down 12.9% q/q and up 28.7% y/y, above the Street's $86.0mn.
Analyst Kevin Cassidy commented, "While we've been... More
Needham and Company Reiterates Hold Rating on Ambarella (AMBA) Following Strong F4Q17 Results; Outlook Lower on GoPro (GPRO) Loss
March 1, 2017 7:13 AM ESTNeedham & Company analyst N. Quinn Bolton maintains Hold rating on Ambarella (NASDAQ: AMBA), as the company produced fiscal 2017 fourth quarter results above expectations, while acknowledging GoPro's (NASDAQ: GPRO) move to an alternative video processor will negative impact... More
Ambarella (AMBA) PT Lowered to $65 at Morgan Stanley
March 1, 2017 3:46 AM ESTMorgan Stanley lowered its price target on Ambarella (NASDAQ: AMBA) to $65.00 (from $70.00) while maintaining a Overweight rating.
Analyst Joseph Moore comments "While 24% customer GoPro has been a long term headwind, it will drop 80% this year as they move to an alternate... More
Dougherty & Co Upgrades Ambarella (AMBA) to Buy
March 1, 2017 3:08 AM ESTDougherty & Co upgraded Ambarella (NASDAQ: AMBA) from Neutral to Buy with a price target of $75.00.
For an analyst ratings summary and ratings history on Ambarella click here. For more ratings news on Ambarella click here.
Shares of Ambarella closed at $58.95 yesterday.
... MoreAfter-Hours Stock Movers 02/28: (DVAX) (BGFV) (DAR) Higher; (PANW) (SRPT) (ENPH) Lower (more...)
February 28, 2017 6:03 PM ESTToday's After-Hours Movers
Dynavax Technologies Corporation (NASDAQ: DVAX) 24.4% HIGHER; announced today that the U.S. Food and Drug Administration (FDA) has accepted for review Dynavax's responses to the Complete Response Letter (CRL) issued by the FDA in November 2016 for the Biologics License Application for HEPLISAV-B, the company's vaccine candidate for immunization against hepatitis B infection in adults 18 years of age and older. The FDA has established August 10, 2017 as the Prescription Drug User Fee Act (PDUFA) action date.
Ambarella (AMBA) Tops Q4 EPS by 18c; Guides Q1 Revs Below Views
February 28, 2017 4:09 PM ESTAmbarella (NASDAQ: AMBA) reported Q4 EPS of $0.92, $0.18 better than the analyst estimate of $0.74. Revenue for the quarter came in at $87.5 million versus the consensus estimate of $86.07 million.
GUIDANCE:
Ambarella sees Q1 2018 revenue of $62.5-64.5 million, versus the... More